Led by InstitutionBuilders.

Mr. B. N. Singh is one of the most respected names in Indian pharmaceuticals and enterprise building.

As Co-Founder and Executive Chairman of Alkem Laboratories, he has played a defining role in shaping one of India’s leading pharmaceutical institutions. His journey reflects decades of conviction, resilience and commitment to making quality healthcare more accessible across India and beyond.

Under his leadership, Alkem evolved from an entrepreneurial venture into a trusted pharmaceutical organization with a strong domestic presence and a meaningful international footprint. His work has been marked by disciplined growth, industry contribution and a deep belief in building institutions that serve a larger purpose.

Mr. Singh has also contributed to the broader pharmaceutical industry through leadership roles across important industry bodies, lending his experience to matters of policy, standards and responsible growth.

At Amplira Ventures, he brings the founding spirit of the platform: enterprise with purpose, capital with responsibility and leadership with a long-term horizon.

Mrs. Madhurima Singh brings a strong blend of board experience, governance maturity and cross-functional business understanding.

Her career spans leadership across healthcare, enterprise and venture-oriented platforms. She has been associated with organizations where governance, compliance, financial management, human resources, supply chain and marketing all come together as part of institution building.

Her strength lies in seeing an organization as a complete operating system. This perspective gives her the ability to support strategy with discipline and governance with balance.

Her leadership has also been recognized at a national level, reflecting her contribution to Indian business and enterprise leadership.

At Amplira Ventures, Mrs. Singh plays an important role in shaping the governance character of the platform and ensuring that the ecosystem remains rooted in responsibility, structure and continuity.

Mr. Aniruddha Singh brings a next-generation strategic lens to Amplira Ventures.

His experience sits at the intersection of healthcare, MedTech, M&A, global markets and emerging technologies. He has worked on strategic initiatives involving medical devices, cross-border partnerships, market entry and growth evaluation.

His academic journey includes exposure to leading global institutions and specialized learning across management, healthcare innovation, artificial intelligence and life sciences. This gives him a perspective that combines institutional thinking with future-facing sectors.

At Amplira Ventures, he contributes to strategic thinking, sectoral exploration and the development of long-term opportunity areas within the broader ecosystem.

Dr. Divya Singh is a distinguished breast and endocrine surgeon, physician-scientist and clinical strategist with expertise across advanced surgical practice, translational research and biomedical innovation.

Her academic and professional journey spans JIPMER, Harvard Medical School and the Emory - Georgia Tech Biomedical Innovation programme. She has contributed to clinical research, regulatory strategy and patent-backed therapeutic development, with published work across oncology and endocrine sciences.

At Amplira Ventures, Dr. Singh brings rigorous scientific insight, deep clinical perspective and a strategic understanding of healthcare innovation and investment.